This post was originally published on this site Xtalks Life Science Webinars Now, with both the FDA and the EMA showing support for eSource, it’s time for drug sponsors and CROs to begin to change the existing industry paradigm in order to implement these advancements...
Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal Oncology at Brigham and Women’s Hospital in...
On October 15th and 16th The Lupus Foundation of America helped to sponsor and participated in The Lupus 21st Century Conference, “Increasing Ancestral Diversity of SLE in Clinical Studies: Overcoming the Barriers”. The ultimate goal of the meeting was to improve...
Mark Terry for Biospace writes: Even clinical trial announcements don’t slow down for Halloween. It was a typically busy week. Here’s a look. Y-mAbs Therapeutics provided a clinical update on its omburtamab for central nervous system (CNS) leptomeningeal metastases...
To harmonize eligibility criteria and radiographic disease assessments in clinical trials of adjuvant therapy for muscle-invasive bladder cancer (MIBC). National experts in bladder cancer clinical trial research, including medical and urologic oncologists,...
Trial opened for patient enrollment in the United States Independent Data Monitoring Committee recommends continuation of the trial as planned LYON, France and CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext: ERYP – Nasdaq:...
Email
Text